Koichi Miyashita

4PUBLICATIONS
11CO-AUTHORS
Disease surveillancePredictive and prognostic markersAllergyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 12, 2026
Increased Risk of Thyrotoxicosis After COVID-19 in Adolescents and Young Adults During the Omicron-Predominant Period: A Nationwide Matched Study.

|Oct 15, 2025
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.

Masato Karayama, Koichi Miyashita, Yusuke Inoue

|Nov 16, 2020
Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.

Koichi Miyashita, Masato Kono, Go Saito

|May 26, 2018
Successful treatment by tolvaptan of the syndrome of inappropriate antidiuretic hormone secretion that may be associated with chemotherapy-induced tumour lysis in a patient with small-cell lung carcinoma.

Koichi Miyashita, Shun Matsuura, Hyogo Naoi

Pageof 1

Frequent Collaborators

2 joint publications

Hironao Hozumi

2 joint publications

Tomoyuki Fujisawa

1 joint publications

Masato Kono

1 joint publications

Masato Karayama